According to Tanaka et al., patients with post-pancreaticoduodenectomy (PD) NASH exhibited lower levels of apolipoprotein B, serum albumin, cholesterol, and Body Mass Index than those with conventional NASH [152]. Here, APOB is linked to metabolic dysfunction-associated steatohepatitis.